An independent guide to cash-pay care. Every price is dated and sourced.

How we check
Wellchosen Health

Medical weight loss in Raleigh

Raleigh patients on NC Medicaid regained GLP-1 coverage for weight management on December 12, 2025, after a two-month gap, with Wegovy as the preferred drug [1]. Paying cash instead, a Raleigh adult spends $149 to $349 a month on Wegovy or $299 to $449 on Zepbound [2] [3].

Updated Oct 17, 2026By the Wellchosen Health editorial team

Medical review: pending. A licensed clinician has not yet reviewed this page.

Medical weight loss is care for obesity supervised by a licensed prescriber, which may include FDA-approved GLP-1 medicine.

NC Medicaid GLP-1 coverage
Reinstated Dec 12, 2025 [1]
Adult obesity, Raleigh
30.9% [4]
Adult diabetes, Wake County
9.5% [5]
Population
506,306 (July 2025) [6]

Compare GLP-1 costs

NC Medicaid's stop and restart

NC Medicaid, both Direct and managed care plans, dropped GLP-1 coverage for weight management on October 1, 2025 during a budget impasse, then restored it effective December 12, 2025 under its earlier prior authorization criteria [1]. Wegovy is the preferred drug; Zepbound and Saxenda require a trial of Wegovy first [1]. KFF's January 2026 review also records North Carolina's drop in October 2025 and its reinstatement in December [7].

Paid placement, clearly marked. It does not represent our view of the practice.

Raleigh and Wake County figures

CDC PLACES estimates 30.9% of Raleigh adults have obesity and 9.1% have diabetes; across Wake County, 29.3% and 9.5% [4] [5]. Raleigh's median household income is $85,395 and 11.9% of residents are 65 or older [6].

Semaglutide and tirzepatide cash prices

Raleigh cash and Medicare prices, as of Oct 17, 2026
RouteWhat you pay monthlySource
Wegovy tablets (semaglutide), NovoCare$149 to $299[2]
Wegovy injection (semaglutide), NovoCare$349, with a $199 intro price[2]
Zepbound (tirzepatide), LillyDirect$299 to $449[3]
Medicare GLP-1 Bridge, if you qualify$50 copay[8]
Drug prices only; a Wake County clinic charges for visits separately. More: semaglutide cost and tirzepatide cost.

Getting a prescription in Raleigh

We found no Raleigh hospital weight program with a posted price this month. Ask your primary care office or health system whether it prescribes GLP-1s and what a self-pay visit costs. The North Carolina Medical Board licenses the state's physicians [9]. For telehealth, see online GLP-1 programs and search our FDA warning letter tracker before paying anyone.

Nearby pages: Charlotte, Richmond, Washington, DC. Also medical weight loss and clinic checklist.

Safety notes for Triangle patients

Rodent studies produced a boxed warning on thyroid C-cell tumors, so neither Wegovy nor Zepbound is for someone with MEN 2 or with medullary thyroid carcinoma in their own or their family's history [10] [11]. Abdominal pain that is intense and lingering, a rash with swelling, or shakiness from low blood sugar while on insulin or sulfonylurea pills all need prompt care. The labels call for stopping once a pregnancy is recognized. Compounded copies lack FDA approval [12]. Dial 911 for a swollen throat or breathing trouble.

Questions people ask

Does NC Medicaid cover Wegovy for weight loss in Raleigh?

Yes. NC Medicaid brought back GLP-1 coverage for weight management on Dec 12, 2025, with Wegovy as the preferred drug and prior authorization required [1].

Can a Raleigh Medicaid member get Zepbound instead?

Only after trying Wegovy first. NC Medicaid lists Wegovy as preferred, and Zepbound and Saxenda require a Wegovy trial [1].

Why did NC Medicaid stop covering GLP-1s in fall 2025?

A state budget impasse. Coverage for weight management stopped on October 1, 2025 and resumed on December 12, 2025 under the earlier prior authorization rules [1].

What do Wegovy and Zepbound cost a Raleigh cash buyer?

As of Oct 17, 2026, the Wegovy pill was $149 to $299 a month and the pen $349 ($199 for two intro fills) [2]; Zepbound was $299 to $449 through LillyDirect [3].

How common is obesity in Raleigh and Wake County?

CDC PLACES estimates 30.9% of Raleigh adults and 29.3% of Wake County adults had obesity in 2023 [4] [5].

What share of Raleigh residents are 65 or older?

11.9%, according to Census QuickFacts, which matters for anyone weighing the Medicare GLP-1 Bridge [6].

Sources

12 cited
  1. NC Medicaid to reinstitute coverage of GLP-1s for weight management. NC Department of Health and Human Services, Dec 19, 2025.
  2. Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
  3. Zepbound self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  4. PLACES place data, 2025 release: Raleigh, NC. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
  5. PLACES county data, 2025 release: Wake County, NC. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
  6. QuickFacts: Raleigh city, North Carolina. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
  7. Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
  8. Weight loss drugs coverage (Medicare GLP-1 Bridge). Medicare.gov (CMS), Oct 17, 2026.
  9. Contact a state medical board. Federation of State Medical Boards, Oct 17, 2026.
  10. Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
  11. Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration, Apr 2026.
  12. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

Compare GLP-1 costs